Aptuit's Preclinical and Clinical Technologies are focused on the critical steps that are essential in taking a novel compound and developing it into a safe and effective treatment. Aptuit provides the span of preclinical services required for aiding lead candidate selection in the form of efficacy pharmacology and early drug metabolism support.
Following candidate selection, Aptuit provides the services required for submission of successful regulatory filings (exploratory or standard), including toxicology studies, safety pharmacology studies and supporting bioanalytical and analytical studies. Aptuit also supports clinical trials with longer term toxicology studies, more complex drug metabolism studies and clinical bioanalytical support. Our experience enables us to support both small molecule and large molecule development programs for worldwide regulatory submission.